THC Farmaceuticals, Inc. Stock
Stocks
CBDG
US87243T1007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
12:16:54 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 0.0240 USD | 0.00% |
|
0.00% | -36.84% |
| 23-02-07 | THC Farmaceuticals, Inc. announced that it expects to receive $0.124 million in funding | CI |
| 21-06-28 | Thc Farmaceuticals, Inc. Announces Final Departure of Mike Gravel, Chairman | CI |
| Market Cap | 6M 5.29M 5.01M 4.54M 8.52M 576M 8.6M 60.09M 23.16M 294M 22.52M 22.03M 946M | P/E 2013 * |
-
| P/E 2014 | -321x |
|---|---|---|---|---|---|
| Enterprise Value | 6.08M 5.36M 5.07M 4.6M 8.63M 583M 8.71M 60.86M 23.46M 298M 22.81M 22.32M 958M | EV / Sales 2013 * |
-
| EV / Sales 2014 | 522x |
| Free-Float |
20.62% | Yield 2013 * |
-
| Yield 2014 | - |
| Current month | -13.98% | ||
| 1 month | -13.98% | ||
| 3 months | +118.18% | ||
| 6 months | +31.87% | ||
| Current year | -36.84% |
| 1 month | 0.01 |  | 0.02 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.09 |
| 3 years | 0 | | 0.1 |
| 5 years | 0 | | 0.25 |
| 10 years | 0 | | 8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Grossman
CEO | Chief Executive Officer | - | - |
Gary Henrie
LAW | General Counsel | 72 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Tobias
BRD | Director/Board Member | 75 | - |
Mark Grossman
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +83.21% | +140.00% | 435K | |
| -0.03% | +3.77% | +12.35% | +37.22% | 49.06B | |
| -0.73% | -0.41% | +48.84% | +36.72% | 44.6B | |
| +1.36% | +6.03% | +343.85% | +638.73% | 43.24B | |
| -0.47% | -0.76% | +9.75% | +103.07% | 41.73B | |
| +0.34% | +0.22% | +5.18% | +47.36% | 29.93B | |
| +1.00% | -1.28% | +24.23% | +156.93% | 17.19B | |
| -3.20% | -3.50% | +25.33% | +42.43% | 15.54B | |
| -2.94% | +6.98% | +5.10% | - | 15.35B | |
| -0.86% | -4.00% | - | - | 15.11B | |
| Average | -0.55% | +17.68% | +61.98% | +150.31% | 27.18B | |
| Weighted average by Cap. | -0.28% | +1.79% | +74.43% | +166.43% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 21.64K 19.1K 18.07K 16.39K 30.72K 2.08M 31.03K 217K 83.54K 1.06M 81.26K 79.49K 3.41M | 19.03K 16.8K 15.89K 14.41K 27.02K 1.83M 27.29K 191K 73.48K 933K 71.47K 69.92K 3M |
| Net income | -23.84K -21.04K -19.9K -18.05K -33.84K -2.29M -34.18K -239K -92.02K -1.17M -89.51K -87.56K -3.76M | -30.7K -27.09K -25.63K -23.24K -43.58K -2.95M -44.01K -307K -119K -1.5M -115K -113K -4.84M |
| Net Debt | 58.16K 51.33K 48.57K 44.04K 82.57K 5.58M 83.39K 583K 225K 2.85M 218K 214K 9.17M | 77.06K 68.01K 64.35K 58.36K 109K 7.39M 110K 772K 298K 3.78M 289K 283K 12.15M |
Employees
-
- Stock Market
- Stocks
- CBDG Stock
Select your edition
All financial news and data tailored to specific country editions
